Over the 90-day window ending January 10, 2026, Iovance Biotherapeutics's three dominant insider ownership positions are held by Director Wayne P. Rothbaum (28.07Mn shares), Director Merrill A Mcpeak (568.78K shares), Interim Ceo & General Counsel Frederick G Vogt (464.52K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Wayne P. Rothbaum | 28,067,333 | 20 Feb, 2024 | |
| Merrill A Mcpeak | 568,783 | 20 Feb, 2024 | |
| Frederick G Vogt | Interim Ceo & General Counsel | 464,522 | 03 Dec, 2025 |
| Raj K. Puri | Chief Regulatory Officer | 215,859 | 03 Dec, 2025 |
| Michael Weiser | 112,632 | 02 Jun, 2022 | |
| Finckenstein Friedrich Graf | Chief Medical Officer | 111,656 | 03 Dec, 2025 |
| Igor Bilinsky | Chief Operating Officer | 105,744 | 03 Dec, 2025 |
| Jean-Marc Bellemin | Chief Financial Officer | 60,529 | 04 Jun, 2025 |
| Iain D. Dukes | 54,000 | 20 Feb, 2024 | |
| Daniel Gordon Kirby | Chief Commercial Officer | 30,000 | 06 Jun, 2025 |
| Ryan D Maynard | 7,500 | 14 Nov, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Dec, 2025 | Igor Bilinsky | Common Stock | A | 3,516 | $0.00 | 107,530 | D | M |
| 02 Dec, 2025 | Igor Bilinsky | Common Stock | D | 1,786 | $2.14 | 105,744 | D | F |
| 02 Dec, 2025 | Frederick G Vogt | Common Stock | A | 10,417 | $0.00 | 468,948 | D | M |
| 02 Dec, 2025 | Frederick G Vogt | Common Stock | D | 4,426 | $2.14 | 464,522 | D | F |
| 02 Dec, 2025 | Finckenstein Friedrich Graf | Common Stock | A | 3,906 | $0.00 | 113,640 | D | M |
| 02 Dec, 2025 | Finckenstein Friedrich Graf | Common Stock | D | 1,984 | $2.14 | 111,656 | D | F |
| 01 Dec, 2025 | Igor Bilinsky | Common Stock | D | 4,464 | $2.23 | 104,014 | D | F |
| 01 Dec, 2025 | Igor Bilinsky | Common Stock | A | 8,789 | $0.00 | 108,478 | D | M |
| 01 Dec, 2025 | Frederick G Vogt | Common Stock | D | 17,701 | $2.23 | 458,531 | D | F |
| 01 Dec, 2025 | Frederick G Vogt | Common Stock | A | 41,669 | $0.00 | 476,232 | D | M |
| 01 Dec, 2025 | Finckenstein Friedrich Graf | Common Stock | A | 8,789 | $0.00 | 114,198 | D | M |
| 01 Dec, 2025 | Finckenstein Friedrich Graf | Common Stock | D | 4,464 | $2.23 | 109,734 | D | F |
| 01 Dec, 2025 | Raj K. Puri | Common Stock | D | 2,467 | $2.23 | 215,859 | D | F |
| 01 Dec, 2025 | Raj K. Puri | Common Stock | A | 5,469 | $0.00 | 218,326 | D | M |
| 02 Sep, 2025 | Igor Bilinsky | Common Stock | D | 6,250 | $2.19 | 99,689 | D | F |
| 02 Sep, 2025 | Igor Bilinsky | Common Stock | A | 12,306 | $0.00 | 105,939 | D | M |
| 02 Sep, 2025 | Frederick G Vogt | Common Stock | A | 52,086 | $0.00 | 456,690 | D | M |
| 02 Sep, 2025 | Frederick G Vogt | Common Stock | D | 22,127 | $2.19 | 434,563 | D | F |
| 02 Sep, 2025 | Finckenstein Friedrich Graf | Common Stock | D | 6,448 | $2.19 | 105,409 | D | F |
| 02 Sep, 2025 | Finckenstein Friedrich Graf | Common Stock | A | 12,697 | $0.00 | 111,857 | D | M |